Table 2.
Antiplatelet medication | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristic | Aspirin only | Clopidogrel only | Aspirin and clopidogrel | Aspirin and dipyridamole | ||||||||
(N = 233) | (N = 95) | (N = 63) | (N = 39) | |||||||||
Population estimate | % | P value | Population estimate | % | P value | Population estimate | % | P value | Population estimate | % | P value | |
| ||||||||||||
Total | 1,194,958 | — | 818,437 | — | 978,810 | — | 366,967 | — | ||||
| ||||||||||||
Race | ||||||||||||
White | 958,151 | 80.2% | 0.40 |
581,489 | 71.0% | 0.68 |
708,008 | 72.3% | 0.91 |
341,339 | 93.0% | 0.11 |
Black | 201,745 | 16.9% | 150,228 | 18.4% | 203,509 | 20.8% | 22,867 | 6.2% | ||||
Other | 35,062 | 2.9% | 86,720 | 10.6% | 67,293 | 6.9% | 2761 | 0.8% | ||||
| ||||||||||||
Region | ||||||||||||
Northeast | 304,874 | 25.5% | 0.38 |
82,604 | 10.1% | 0.52 |
111,832 | 11.4% | 0.47 |
62,510 | 17.0% | 0.75 |
Midwest | 217,812 | 18.2% | 287,327 | 35.1% | 161,843 | 16.5% | 108,731 | 29.6% | ||||
South | 433,594 | 36.3% | 259,449 | 31.7% | 466,195 | 47.6% | 84,482 | 23.0% | ||||
West | 238,678 | 20.0% | 189,057 | 23.1% | 238,940 | 24.4% | 111,244 | 30.3% | ||||
| ||||||||||||
Age | ||||||||||||
18–44 years | 65,453 | 5.5% | 0.39 |
10,958 | 1.3% | 0.03 | 17,561 | 1.8% | 0.20 |
12364 | 3.4% | 0.90 |
45–64 years | 436,552 | 36.5% | 116,735 | 14.3% | 404,818 | 41.4% | 95,313 | 26.0% | ||||
≥65 years | 692,953 | 58.0% | 690,744 | 84.4% | 556,431 | 56.8% | 259,290 | 70.7% | ||||
| ||||||||||||
Gender | ||||||||||||
Female | 632,517 | 52.9% | 0.71 |
522,671 | 63.9% | 0.15 |
192,540 | 19.7% | <0.01 | 113,778 | 31.0% | 0.22 |
Male | 562,441 | 47.1% | 295,766 | 36.1% | 786,270 | 80.3% | 253,189 | 69.0% | ||||
| ||||||||||||
Insurancec | ||||||||||||
Private insurance | 355,686 | 29.8% | 0.31 |
187,508 | 22.9% | 0.47 |
405,119 | 41.4% | 0.21 |
64,802 | 17.7% | 0.73 |
Medicare | 656,260 | 54.9% | 572,429 | 69.9% | 461,148 | 47.1% | 267,898 | 73.0% | ||||
Medicaid | 71,523 | 6.0% | 26,884 | 3.3% | 53,025 | 5.4% | 10,678 | 2.9% | ||||
Other | 55,345 | 4.6% | 21,151 | 2.6% | 14,927 | 1.5% | 10,620 | 2.9% | ||||
| ||||||||||||
Location | ||||||||||||
MSAd | 994,903 | 83.3% | 0.82 |
646,403 | 79.0% | 0.58 |
852,053 | 87.0% | 0.72 |
224,322 | 61.1% | 0.30 |
Non-MSA | 200,055 | 16.7% | 172,034 | 21.0% | 126,757 | 13.0% | 142,645 | 38.9% | ||||
| ||||||||||||
Setting | ||||||||||||
Physician office | 711,071 | 59.5% |
0.05
|
726,058 | 88.7% |
<0.01
|
870,856 | 89.0% |
0.01
|
317,518 | 86.5% | 0.21 |
Hospital OPDe | 56,218 | 4.7% | 49,195 | 6.0% | 5,305 | 0.5% | 8,951 | 2.4% | ||||
Hospital ED | 427,669 | 35.8% | 43,184 | 5.3% | 102,649 | 10.5% | 40,498 | 11.0% | ||||
| ||||||||||||
Year | ||||||||||||
2000-01 | 360,067 | 30.1% | 0.13 |
107,873 | 13.2% | 0.22 |
23,542 | 2.4% |
<0.01
|
118,183 | 32.2% | 0.62 |
2002-03 | 244,855 | 20.5% | 151,764 | 18.5% | 192,779 | 19.7% | 47,861 | 13.0% | ||||
2004-05 | 213,034 | 17.8% | 327,148 | 40.0% | 456,787 | 46.7% | 104,817 | 28.6% | ||||
2006-07 | 377,002 | 31.5% | 231,652 | 28.3% | 305,702 | 31.2% | 96,106 | 26.2% |
aNAMCS: National Ambulatory Medical Care Survey, NHAMCS: National Hospital Ambulatory Medical Care Survey.
bPopulation estimates were calculated using SAS-callable SUDAAN software, version 9.0.1 (Research Triangle Institute) to obtain proper variance estimations that accounted for the complex sampling design of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey and results that were weighted to reflect national population estimates.
cInsurance (payment source) does not sum to 100% because of missing data, dMSA: Metropolitan Statistical Area.
eOPD: Outpatient Department.